SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-041271
Filing Date
2020-12-07
Accepted
2020-12-07 14:33:13
Documents
1
Period of Report
2020-11-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2119
  Complete submission text file 0001213900-20-041271.txt   3522
Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019
Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2443 FILLMORE ST #380-17649 SAN FRANCISCO CA 94115
Business Address
Pamir Ozan (Reporting) CIK: 0001834681 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38105 | Film No.: 201372406